Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen J Murphy

Showing results (71-80 of 76) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 76 results.
Iscience|July 4, 2025
Functional impact of the hyperduplication genomophenotype in high copy number endometrial cancerAngela Florio, James Smadbeck, Sarah H Johnson, et al.
Epigenomics|May 22, 2023
Epigenomics may begin to explain <i>in vitro</i> differential response to hypomethylating agents in MMR-D hypermethylated endometrial cancerLouis Y El Khoury, Wan Hsin Lin, James B Smadbeck, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 28, 2025
Personalized Tumor-Specific Amplified DNA Junctions in Peripheral Blood of Patients with High-Grade GliomasMohamed F Ali, Cecile Riviere-Cazaux, Sarah H Johnson, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|January 10, 2026
Prognostic value of perioperative circulating tumor DNA (ctDNA) in endometrial cancer with high-risk features: a prospective observational studyLuigi A De Vitis, Faye R Harris, Leah Grcevich, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 11, 2026
DNA-junction-based personalized liquid biopsy assays could inform management of aggressive endometrial cancerFaye R Harris, Luigi A De Vitis, Leah Grcevich, et al.
Biorxiv : the Preprint Server for Biology|February 12, 2026
Functional genomics identifies therapeutic options, biomarkers, and resistance mechanisms for high-grade gliomasWan-Hsin Lin, Farhad Kosari, James B Smadbeck, et al.
Pageof 8

Showing results (71-80 of 76) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 76 results.
Iscience|July 4, 2025
Functional impact of the hyperduplication genomophenotype in high copy number endometrial cancerAngela Florio, James Smadbeck, Sarah H Johnson, et al.
Epigenomics|May 22, 2023
Epigenomics may begin to explain <i>in vitro</i> differential response to hypomethylating agents in MMR-D hypermethylated endometrial cancerLouis Y El Khoury, Wan Hsin Lin, James B Smadbeck, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 28, 2025
Personalized Tumor-Specific Amplified DNA Junctions in Peripheral Blood of Patients with High-Grade GliomasMohamed F Ali, Cecile Riviere-Cazaux, Sarah H Johnson, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|January 10, 2026
Prognostic value of perioperative circulating tumor DNA (ctDNA) in endometrial cancer with high-risk features: a prospective observational studyLuigi A De Vitis, Faye R Harris, Leah Grcevich, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 11, 2026
DNA-junction-based personalized liquid biopsy assays could inform management of aggressive endometrial cancerFaye R Harris, Luigi A De Vitis, Leah Grcevich, et al.
Biorxiv : the Preprint Server for Biology|February 12, 2026
Functional genomics identifies therapeutic options, biomarkers, and resistance mechanisms for high-grade gliomasWan-Hsin Lin, Farhad Kosari, James B Smadbeck, et al.
Pageof 8